Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins as anti-inflammatory agents.

Gabriele Weitz-Schmidt1

  • 1Novartis Pharma AG, Preclinical Research, Basel, Switzerland. gabriele.weitz@pharma.novartis.com

Trends in Pharmacological Sciences
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decrypting Integrins by Mixed-Solvent Molecular Dynamics Simulations.

Journal of chemical information and modeling·2023
Same author

Allosteric targeting resolves limitations of earlier LFA-1 directed modalities.

Biochemical pharmacology·2023
Same author

Anti-αLβ2 antibodies reveal novel endocytotic cross-modulatory functionality.

British journal of pharmacology·2020
Same author

Historical account and current research of pharmacology in Switzerland.

Pharmacological research·2019
Same author

Introductory letter by the guest editors.

Pharmacological research·2019
Same author

Parallel Synthesis of Sialyl Lewis X Mimetics on a Solid Phase: Access to a Library of Fucopeptides.

Angewandte Chemie (International ed. in English)·2018
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
Same journal

Which HTT transcript to lower?

Trends in pharmacological sciences·2026
See all related articles

Statins, used for cardiovascular disease, offer anti-inflammatory benefits beyond lowering cholesterol. Research explores how these drugs impact leukocyte adhesion and migration, suggesting new therapeutic avenues.

Area of Science:

  • Pharmacology
  • Immunology
  • Cardiovascular Medicine

Background:

  • Cardiovascular disease treatments often involve 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins).
  • Statins' cardiovascular benefits are traditionally linked to cholesterol reduction.
  • Emerging evidence suggests statins possess direct anti-inflammatory properties independent of cholesterol levels.

Purpose of the Study:

  • To review the mechanisms of statin action on leukocyte adhesion and migration.
  • To explore both HMG-CoA-reductase-dependent and -independent pathways.
  • To discuss implications for developing novel statin-derived anti-inflammatory drugs.

Main Methods:

  • Review of in vitro and in vivo studies on statin effects.
  • Analysis of HMG-CoA-reductase-dependent mechanisms.

Related Experiment Videos

  • Analysis of HMG-CoA-reductase-independent mechanisms.

    • Main Results:

    • Statins exhibit anti-inflammatory effects not solely due to cholesterol lowering.
    • Statins influence leukocyte adhesion and migration through various pathways.
    • Both HMG-CoA-reductase-dependent and -independent mechanisms are involved.

    Conclusions:

    • Statins have pleiotropic effects extending beyond lipid modification.
    • Understanding these non-lipid-lowering effects is crucial for cardiovascular health.
    • Further research into statin-derived compounds could yield targeted anti-inflammatory therapies.